About National Alzheimer's Disease Awareness

Sign up and be counted as a Champion!

Sign up and be counted as a Champion!

First name:
.
Last name:
.
E-mail:
.
ZIP:
.
Check to receive email

Labels

Alzheimer's disease (15) Health (10) Conditions and Diseases (9) United States (8) ALZHEIMER'S (7) Dementia (6) Jasmine Elisa (6) Alzheimer's Association (5) Neurological Disorders (5) alzheimers (4) Awareness (3) Long term care insurance (3) Maria Shriver (3) NORM MAC (3) White House (3) Disease (2) Green tea (2) New York Times (2) South Korea (2) Tea (2) Traditional Chinese medicine (2) United States Disease Alzheimer's disease Chicago Health Alzheimers disease older americans Dementia Conditions and Diseases (2) Winnipeg (2) Winnipeg Free Press (2) ...In Translation (1) Adalimumab (1) Alprazolam (1) Alzheimer (1) Alzheimers disease (1) American Academy of Neurology (1) Austin Hospital Melbourne (1) Barack Obama (1) Beta amyloid (1) Body mass index (1) Cancer (1) Cognition (1) Dallas (1) Digestion (1) Doctor of Philosophy (1) Etanercept (1) Facebook (1) Facebook features (1) Florida (1) Food (1) Infliximab (1) Insurance (1) Jae Hee (1) Jerry Brown (1) Karolinska Institutet (1) Kim Hye-jin (1) Los Angeles (1) Melbourne (1) Mental Health Research Institute (1) Mexico (1) Microsoft PowerPoint (1) Mouse (1) New America Media (1) Newcastle University (1) Non-steroidal anti-inflammatory drug (1) Nursing home (1) Obesity (1) Pete Rouse (1) Physical examination (1) Positron emission tomography (1) Rheumatoid arthritis (1) Sandra Day O'Connor (1) Selective serotonin reuptake inhibitor (1) Seoul (1) Silicon Valley (1) Stockholm (1) Support group (1) THE NEW YORK TIMES COMPANY (1) TNF inhibitor (1) Twitter (1) University of Texas Southwestern Medical Center (1) Xanax (1) is (1) jasmine beltran Los Angeles (1)

Saturday, April 30, 2011

Fisher Center Scientists Show That Anti-Inflammatory Drugs Reduce Effectiveness of SSRI Antidepressants | Fisher Center for Alzheimer's Research Foundation


Fisher Center Scientists Show That Anti-Inflammatory Drugs Reduce Effectiveness of SSRI Antidepressants | Fisher Center for Alzheimer's Research Foundation  



Fisher Center Scientists Show That Anti-Inflammatory Drugs Reduce Effectiveness of SSRI Antidepressants


Scientists at the Fisher Center for Alzheimer’s Disease Research at The Rockefeller University, led by Paul Greengard, Ph.D., and Jennifer Warner-Schmidt, Ph.D., have shown that anti-inflammatory drugs, which include ibuprofen, aspirin and naproxen, reduce the effectiveness of the most widely used class of antidepressant medications, the selective serotonin reuptake inhibitors, or SSRIs, taken for depression, obsessive-compulsive disorder and anxiety disorders. This surprising discovery, published online this week in the Proceedings of the National Academy of Sciences, may explain why so many depressed patients taking SSRIs do not respond to antidepressant treatment and suggests that this lack of effectiveness may be preventable. The study may be especially significant in the case of Alzheimer’s disease. Such patients commonly suffer from depression and unless this can be treated successfully, the course of the illness is likely to be more severe. Depression in the elderly is also a risk factor for developing Alzheimer’s disease and researchers have suggested that treating depression in the elderly might reduce the risk of developing the disease.
In the recent study, investigators treated animal models with antidepressants in the presence or absence of anti-inflammatory drugs. They then examined how the models behaved in tasks that are sensitive to antidepressant treatment. The behavioral responses to antidepressants were inhibited by anti-inflammatory/analgesic treatments. They then confirmed these effects in a human population. Depressed individuals who reported anti-inflammatory drug use were much less likely to have their symptoms relieved by an antidepressant than depressed patients who reported no anti-inflammatory drug use. The effect was rather dramatic since, in the absence of any anti-inflammatory or analgesic use, 54% of patients responded to the antidepressant, whereas, success rates dropped to approximately 40% for those who reported using anti-inflammatory agents.
“The mechanism underlying these effects is not yet clear. Nevertheless, our results may have profound implications for patients, given the very high treatment resistance rates for depressed individuals taking SSRIs,” noted Dr. Warner-Schmidt. Dr. Greengard added, “Many elderly individuals suffering from Alzheimer’s disease also have arthritic or related diseases and as a consequence are taking both antidepressant and anti-inflammatory medications. Our results suggest that physicians should carefully balance the advantages and disadvantages of continuing anti-inflammatory therapy in patients being treated with antidepressant medications.”
This is the third significant finding in nine months by Fisher Scientist in Dr. Greengard’s lab. Previously, Fisher Center researchers headed by Nobel laureate Dr. Paul Greengard in the Fisher laboratory at The Rockefeller University found two new ways to control beta-amyloid. In September of 2010 published in Nature, they discovered a previously unknown function for a protein in the brain that stimulates the production of beta-amyloid which is known to contribute to the cause of Alzheimer’s. Controlling this protein, called gSAP, is a key and also has the advantage of not interfering with other life functions which caused the failure of many earlier drug trials. In another finding published in the FASEB Journal in March 2011, they also succeeded in accelerating the breakdown of accumulated beta-amyloid. They discovered that a process called autophagocytosis reduces the buildup of beta-amyloid in isolated cells and might be utilized to eliminate the buildup of beta-amyloid in the brains of Alzheimer’s patients. They discovered that a compound called SMER28 lowers the level of beta-amyloid found in nerve cells. According to Dr. Greengard, “the combination of inhibition of formation and acceleration of breakdown of beta-amyloid represents a new and powerful strategy for treating Alzheimer’s disease.”
“This is the third major finding by the Fisher Center scientists at the Greengard lab in only nine months,” says Kent L. Karosen, President of the Fisher Center for Alzheimer’s Research Foundation. “It’s quite amazing that their novel techniques are proving to be so prolific. This latest finding shows their success in not only one day ending Alzheimer’s, but in also having even broader implications for society.”
The Fisher Center for Alzheimer’s Research Foundation is a leading source of funding for Alzheimer’s research and education. They serve Alzheimer’s patients and their families by seeking to understand the causes of, discover a cure for, and improve the lives of people with Alzheimer’s disease. Nobel laureate Dr. Paul Greengard directs the Foundation’s team of internationally renowned scientists. Of the money raised by the Foundation, only 9 cents out of every dollar is used for overhead and administrative purposes. For more information about the Fisher Center for Alzheimer’s Research Foundation,click here.

Thursday, April 28, 2011

California Budget Cuts at Odds With State’s New Alzheimer’s Plan

Alzheimer's patient Felipe Garcia, at right in above photo, is shown with his sons Marco, left, and Oscar, center.

Part 1 of 2. Read Part 2 here. 

MOUNTAIN VIEW, Calif.—Felipe Garcia, 79, looks up with a ready smile as his two-year-old granddaughter, Marina, orbits his shuffling legs—her mother Elena keeping a sharp eye on the toddler to avoid any mishaps around the family’s modest home in Silicon Valley. Elena says Marina doesn’t quite understand yet that her abuelo (grandpa) has Alzheimer’s disease and can’t concentrate on her for long periods of time. 

Felipe, who migrated from Mexico in his youth, is among 5.5 million Americans diagnosed with Alzheimer’s. Of those cases, 588,000 are in California, a number that is expected to double by 2030. The number of Latinos and Asians living with the disease will triple during the same time period, according to a new state plan jointly released by the Alzheimer’s Association, California’s Health and Human Services Agency and the Alzheimer’s Disease and Related Disorders Advisory Committee.

Yet the plan’s chief recommendation—to meet the projected shortage of caregiving resources by expanding home and community services, thus keeping people out of costly nursing homes—may be in jeopardy. Last Thursday, Gov. Jerry Brown signed into law the latest round of budget cuts to services the Garcias rely on to manage care for both Felipe and his wife Manuela, 65, who has diabetes, heart disease and other ailments. 

Three Garcia Households Under One Roof

California’s new Alzheimer’s plan shows that families like the Garcias provide three-quarters of the intensive care for those afflicted with the illness. Only 6 percent of Alzheimer’s patients are in nursing homes, and many families go to great lengths to keep their loved ones out of institutions. 

Three households of Garcias—those of Felipe and Manuela, their son Marco and his wife Elena, and their son Oscar—took the unusual step of pooling their resources to purchase the home the elder Garcias had rented for decades. They rebuilt it with six bedrooms and a basement, enough space to house the entire family. 

The two sons and daughter-in-law divide daily labors of love, such as preparing meals, managing multiple medications and getting Felipe and Manuela to doctor’s appointments. 

“It gets a little hectic,” says Marco, a Mountain View police officer, who works night shifts. “You’re trying to eat dinner, the kids [are] running around—everyone’s on a different schedule.”

Then, he said, there are those Alzheimer’s moments. Sometimes Felipe “wakes up stubborn,” Marco says. For instance, he may insist on going up to the attic, a potentially dangerous climb for the frail older man. “So I spend 10 minutes going back and forth about why he shouldn’t go to the attic.”

A key conclusion of the Alzheimer’s plan for California—one of 26 states to develop a plan so far—is that dedicated families such as the Garcias still need help to manage the labor-intensive challenges of caregiving. 

The plan cites one indication of how arduous dementia care is: The cost of nursing home care for Alzheimer’s patients on MediCal (California’s Medicaid program) is 2.5 times greater than that of seniors without the disease.

California Cuts Care, While Other States Expand It

Faced with a fiscal crisis, California has been cutting exactly the kinds of programs the state plan prescribes. Some experts say the cuts actually will drive up costs and unnecessarily force many elders into expensive nursing homes or hospitals. 

The new Alzheimer’s plan asserts, “Unless the state takes steps to provide better support in the home and community for those who are affected by this condition, volume [of Alzheimer’s cases] alone will cripple public resources.” 

The report emphasizes that programs such as California’s In-Home Supportive Services (IHSS) and Adult Day Health Care (ADHC) help keep elders like Felipe Garcia in the family fold. 

However, California lawmakers have cut funding for the state’s 310 ADHCs by more than half, to $85 million. That represents a compromise; in his original budget, Brown called for eliminating the program entirely. The new law also would bring federal matching funds, but only by restructuring the program with federal approval, a process that could take months.

“Nothing good can come from 50-plus percent reductions,” says Marty Lynch, executive director of the nonprofit LifeLong Medical Care in Berkeley. “A lot fewer patients and probably fewer services.”

Lydia Missaelides, who heads the California Association of Adult Day Services, adds that even if the transition to the new funding design is seamless—avoiding family disruption and possible center closures for lack of funds—the strict new eligibility rules and huge cuts will leave many families scrambling. 

“These are people who the state already qualified as at-risk for a nursing home,” she explains. But because ADHC patients now must be at high medical risk of being institutionalized, a borderline patient—for example, someone at an earlier stage of the illness—would lose the preventive nursing care provided by the center and end up seeking emergency services.

Among numerous other budget cuts are $1.7 billion slashed from MediCal and $486 million from IHSS. Fortunately, Missaelides says, the reductions in home assistance—which already suffered deep cuts last year—will be partly offset by funds from the federal Community First Choice program, part of the health care reform law. But more cuts are on the way, including $2.5 million expected to be cut from the case management program for seniors.

This year’s program cuts would curtail assistance to 400,000 vulnerable Californians, who will be forced to turn to more costly emergency care.

“By limiting the availability of these services to only people who are already at an acute level of need, we erase the tremendous savings potential of prevention,” says Wendy Peterson, director of the Senior Services Coalition of Alameda County.

In fact, 32 states dealing with budget crises have actually chosen to expand home- and community-based care programs to save money in the long term, according to a 2010 survey by the Kaiser Family Foundation.

But for H.D. Palmer of the California Department of Finance, “These choices are difficult but necessary.” He insists that the state’s $26.6 billion deficit leaves lawmakers little alternative but to reduce funds for many popular programs. 

Meanwhile, according to the new Alzheimer’s plan, by 2030, nearly 1.2 million elders in the Golden State will suffer from the incurable disease—with state costs more than doubling from today’s expenditures to $31.3 billion a year.

Alzheimer’s also costs California businesses up to $1.4 billion a year in lost productivity, according to the report, as caregivers miss work, cut their hours or switch jobs.

The report, “California’s State Plan For Alzheimer’s Disease: An Action Plan for 2011-2021,” was ordered by the Legislature to address the looming public health crisis as people live longer with chronic illnesses.

It was the culmination of a two-year effort involving state agencies, nonprofit organizations, and more than 2,500 people ranging from experts to family caregivers and Alzheimer’s patients themselves. Also supporting the project were the California Endowment and the SCAN, Gilbert and Archstone foundations.

Research included an online survey of 1,320 caregivers in English, Spanish, Korean, Vietnamese and Chinese.

Investment in the Middle Class

Oscar Garcia, Felipe and Manuela’s son, is the president and CEO of the Mountain View Chamber of Commerce and a member of the Alzheimer’s Association board in Northern California. He says that working professionals, as well as the poor, need the state’s family caregiving assistance. 

“When you look at the medical cost for a facility that specializes in Alzheimer’s, it is prohibitively expensive,” he says.

Like millions of Americans, Oscar found himself “very, very surprised” to learn that Medicare does not cover long-term care services and that affordable private long-term care insurance was not available for his parents. 

“IHSS and adult day care essentially fill in the gap for middle-income people,” Oscar says. “What those programs do is bridge the gap and allow middle America to continue to work and be productive and contribute their taxes, which go back into the economy to be able to fund and provide more. Middle America I view as the engine that pulls this economy.”

Sitting in the Garcias’ living room surrounded by framed family photographs, Oscar chuckles when asked about the collection of carved white elephants on a shelf. 

“Dad loves them,” Oscar says. Replying to the next question, he laughs, “No, he’s a Democrat. I’m a Republican, but he’s a Democrat.”
This is the first of two articles.
Enhanced by Zemanta

Breathing 4 Life's Memory: Lost in translation: As elderly Latino population ...

Breathing 4 Life's Memory: Lost in translation: As elderly Latino population ...: "Lost in translation : As elderly Latino population booms, a rush to boost knowledge of Alzheimer's Discussion By SUZETTE LABOY - Associated ..."

Lost in translation: As elderly Latino population booms, a rush to boost knowledge of Alzheimer's


Lost in translation: As elderly Latino population booms, a rush to boost knowledge of Alzheimer's
DiscussionBy SUZETTE LABOY - Associated Press
Posted: Wednesday, March 30, 2011 12:01 am |


Ida and William Gonzalez bring in the laundry at their home in Davie, Fla. When Ida was diagnosed with Alzheimer's disease, her husband knew little about the scourge that was gradually robbing his wife of a lifetime of memories. (AP Photo/Lynne Sladky)
DAVIE, Fla. ---- William Gonzalez's world collapsed when his wife of more than 50 years was diagnosed with Alzheimer's disease four years ago. The 78-year-old Cuban immigrant knew little about the scourge that was gradually robbing his wife of a lifetime of memories.
Today, the Air Force veteran struggles to run his home in Davie, Fla., while serving as sole caretaker for his 74-year-old wife, Ida.
In increasing numbers, Latinos are facing the wrenching prospect of helping a loved one battle the most common form of dementia. The population of elderly Latinos is projected to grow the fastest of all U.S. racial and ethnic groups in coming years, from just under 3 million in 2008 to 17.5 million in 2050, according to the Federal Interagency Forum on Aging-Related Statistics.
That has Alzheimer's groups pushing to raise awareness among Latinos who are living longer, into the decades when the risk of Alzheimer's rises dramatically.
The Alzheimer's Association "Know the 10 Signs" workshop in Spanish is being offered at the more than 70 chapters nationwide.
A support group started by The Latino Alzheimer's & Memory Disorders now meets twice monthly in different Chicago locations. In Milwaukee, the Latino Geriatric Center provides screenings for memory loss and support groups.
Complications from Alzheimer's is the sixth leading cause of death for non-Hispanics and 12th leading cause of death among Hispanics, according to data from the Centers for Disease Control and Prevention in Atlanta. Yet the nation's largest, private nonprofit funder of Alzheimer's research ---- the Alzheimer's Association ---- warns that the number of older Latinos with Alzheimer's and related dementias could rise more than sixfold from fewer than 200,000 cases today to as many as 1.3 million by 2050, based on rates of population growth.
"We want to make sure we increase concern and awareness as much as we can and extend our services and support," said Janis Robinson, an association official.
Experts say some Latinos are reluctant to make medical appointments, which means long delays from when symptoms are first noticed until a neurologist is seen. When they do decide to see a doctor, it can be a challenge finding one fluent in Spanish.
Add to that the stigma often attached to mental illness ---- the Spanish word for dementia is "demencia," which roughly translates as "crazy" ---- and Latinos face daunting barriers to frank discussion about such diseases.
"I look at it as what cancer was 10 or 15 years ago. People never talked about it or the c-word," said Serge Morales, 72, a retiree of Mexican descent in Agoura Hills.
He and his wife, Susan, knew little about dementia until she was diagnosed at 58 with early-onset Alzheimer's. Susan Morales, who has a nursing degree, has made Los Angeles-area speaking appearances to raise awareness about a disease normally associated with the elderly.
"She's very young-looking, and we just want to make sure that people understand that it can happen to you at a young age," Sergio Morales said.
Dr. Elizabeth Crocco, an Alzheimer's expert at the University of Miami School of Medicine, recalls one patient who was living in Puerto Rico and whose siblings hid her disease from her grown children in Miami. When her son discovered his mother had problems driving and paying the bills, he moved her to Florida for treatment.
"They got angry at him for taking her away," Crocco said of the older siblings. "It was the professional younger son against the older generation."
Arturo Flores, 38, a technician, is the youngest of four children and lives with his parents in Culver City. His Mexican father, Ricardo, has Alzheimer's. Flores, who is single, said caring for his father has affected his life more than he expected, but he feels a duty to the father who raised him.
"I can't really talk to him about certain things in my life I wish I could," said Flores, who has cried many times since his father's diagnosis. "He can't get his ideas out anymore. I see him more as my son now."
In South Florida, Gonzalez's wife was diagnosed four years ago after someone noticed she was speaking English to a Spanish-speaking friend. Now he's struggling with the toll of coping with her disease, vexed when she barely noticed the Christmas ornaments he put up at their home for the holidays.
"That's kind of frustrating, but it's not her. It's the disease," said Gonzalez, who sought relief at weekly support meetings with others who care for Alzheimer's patients.
Fighting back tears, he recalled how he asked his three grown children for their support shouldering the load his wife's disease has placed on him: "You better keep me alive, or try to. Because if I'm OK and here, I can take care of her," he said.
___
Online:
Alzheimer's Association: http://www.alz.org/documents_custom/report_alzfactsfigures2010.pdf
http://www.alz.org/alzheimers_disease_10_signs_of_alzheimers.asp
Copyright 2011 North County Times - The Californian. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Posted in Health-med-fit on Wednesday, March 30, 2011 12:01 am | Tags: Health, News,







Enhanced by Zemanta

Monday, April 25, 2011

Breathing 4 Life's Memory



ACT To END AD !